肺癌合并上腔静脉梗阻的血管内支架治疗  

Expendable Metallic Stents in the Treatment of Superior Vena Cava Syndrome Caused by Lung Cancer

作　　者：谢晓东[1] 廖正银[1] 官泳松 卢武胜[1] 陈清圣[1] 焦和 陈宏汉[1] 胡淑雨[1] 

机构地区：[1]华西医科大学附属第一医院放射科

出　　处：《中国胸心血管外科临床杂志》1997年第4期216-218,共3页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

摘　　要：探讨上腔静脉内支架（ｓｔｅｎｔ）置入治疗原发性肺癌合并上腔静脉梗阻（ＳＶＣＯ）的临床疗效。方法采用经皮穿刺股静脉插管的方法对５例肺癌合并上腔静脉梗阻的患者分别向狭窄上腔静脉置入一枚直径１０ｍｍ或１４ｍｍ，长６０ｍｍ或７０ｍｍ的镍钛记忆合金支架。结果全部患者支架置入一次成功，上腔静脉血流恢复通畅。４例患者ＳＶＣＯ症状很快消除。其中２例患者成活４月和２０月，无复发；２例患者术后４月和５月因肺癌死亡时ＳＶＣＯ亦无复发。１例患者术后短期内复发，经溶栓治疗后症状明显改善。结论血管内支架治疗肺癌合并ＳＶＣＯ是一种有效的姑息治疗方法。为了延长这类患者的生存期。Objective To study the clinical effects of expendable metallic stents (STENT) in the treatment of superior vena cava obstruction (SVCO) due to primary lung carcinoma. Methods Five patients with SVCO due to the lung cancer were treated by a piece of NickelTitanium memorial alloying stent respectively, which is 10 mm or 14mm in diameter, 60mm or 70mm in length. All the stenting procedures were made through percutaneous right femoral veinous route up to the site of superior venacaval obstruction. Results Successful positioning of the stents and the patency of SVCO were achieved in all patients. the symptoms of SVCO completely disappeared without recurrence in 4 patients,but two of them died 4 months and 5 months later because of tumor progression, and two patients were still alive at 4 months and 20 months separately. In one patient, the recurrence of symptoms occurred shortly after stenting, but improvement was observed after thrombolytic therapy. Conclusion The application of stent in patients with SVCO due to lung cancer appears to be an effective palliative procedure. To keep the patients alive longer, the appropriate treatment to the primary lung cancer is important.

关 键 词：肺肿瘤 上腔静脉梗阻 血管内支架 治疗 

分 类 号：R734.205[医药卫生—肿瘤] R654.305[医药卫生—临床医学]